from FOX News https://ift.tt/2Me49m5
GSK, Sanofi start new COVID-19 vaccine study after setback
GlaxoSmithKline and Sanofi on Monday announced the start of a new Phase 2 trial involving their protein-based COVID-19 vaccine candidate after facing a setback in December.
from FOX News https://ift.tt/2Me49m5
from FOX News https://ift.tt/2Me49m5
Related Posts:
WHO official walks back statement that asymptomatic transmission is 'very rare'- FOX NEWS: WHO official walks back statement that asymptomatic transmission is 'very rare'
- FOX NEWS: Arizona tattoo artist keeps an eye out for skin cancer as it might save customers' lives
- Nebraska sees first cases of rare coronavirus-linked inflammatory syndrome in kids
- Arizona tattoo artist keeps an eye out for skin cancer as it might save customers' lives
0 comments:
Post a Comment